Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

High-risk Percutaneous Coronary Intervention clinical trials

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

High-risk Percutaneous Coronary Intervention: 2 US clinical trials tracked, none currently recruiting.

High-risk Percutaneous Coronary Intervention is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Abiomed, running 1 of these trials.

Enrollment posture brief

Registry condition high-risk-percutaneous-coronary-intervention

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%High-risk Percutaneous C (th…0%
Open-enrollment share among volume-matched conditions near High-risk Percutaneous Coronary Intervention

High-risk Percutaneous Coronary Intervention has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for High-risk Percutaneous Coronary Intervention on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. High-risk Percutaneous Coronary Intervention is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on High-risk Percutaneous Coronary Intervention records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

VITALYST System Device
1 trials
Impella ECP Device
1 trials

US sites by state

Facility locations filed on High-risk Percutaneous Coronary Intervention trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
Michigan 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this High-risk Percutaneous Coronary Intervention page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No High-risk Percutaneous Coronary Intervention trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Abiomed sponsors the most High-risk Percutaneous Coronary Intervention trials on record, review their full trial history before evaluating a specific study. See Abiomed's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This High-risk Percutaneous Coronary Intervention condition card totals 2 registered trials; most-linked intervention VITALYST System; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.